Loading…

HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis

ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 2017-07, Vol.102 (7), p.607-611
Main Authors: Skrabl-Baumgartner, Andrea, Christine Hauer, Almuthe, Erwa, Wolfgang, Jahnel, Jörg
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3
cites cdi_FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3
container_end_page 611
container_issue 7
container_start_page 607
container_title Archives of disease in childhood
container_volume 102
creator Skrabl-Baumgartner, Andrea
Christine Hauer, Almuthe
Erwa, Wolfgang
Jahnel, Jörg
description ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD in children with JIA.Patients and interventions95 patients with JIA were screened for CD using CD-specific antibodies. In case of positivity, a small intestinal biopsy was performed to confirm diagnosis. In addition, HLA genotyping was performed. 110 age-matched and sex-matched Caucasian children from the same geographical area served as controls.ResultsCD was diagnosed in 4 of 95 patients with JIA (4.2%), a rate significantly higher compared with controls (p
doi_str_mv 10.1136/archdischild-2016-311544
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1916378157</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A506919505</galeid><sourcerecordid>A506919505</sourcerecordid><originalsourceid>FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3</originalsourceid><addsrcrecordid>eNqNkU-P0zAQxSMEYrsLXwFZ4sIlix3_zbGqgEWqtBc4W44zaVy5drEdYL89LlkQ4gInS-Pfm3kzr2kQwbeEUPHWJDuPLtvZ-bHtMBEtJYQz9qTZECZULTH2tNlgjGnbK6WumuucjxiTTin6vLnqVEc7xtWmCXf7LTpAiOXh7MIBmYwml3JpvQuAsk0A4VIvMXo0xYRsBO-MRXU8mAzIBfTTRoKAvrkyo-PytUp8_RldPJsyO4tMKnNyxeUXzbPJ-AwvH9-b5vP7d592d-3-_sPH3XbfDtVVaSWTowAKgnR4AEE5ldJOprcSjOinCSYAxuyoaE-kGGQv-TDakdCRGyH4SG-aN2vfc4pfFshFn-q5wHsTIC5Zk54IKhXh8t-okh2XUkla0dd_oce4pFAXuTSsB8U9w5VqV-pgPGgXbAwFvhcbvYcD6Lrn7l5vORY96TnmlVcrb1PMOcGkz8mdTHrQBOtL3PrPuPUlbr3GXaWvHg0twwnG38Jf-VaArsBwOv5_2x_657p3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1912450940</pqid></control><display><type>article</type><title>HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis</title><source>Social Science Premium Collection</source><source>Education Collection</source><creator>Skrabl-Baumgartner, Andrea ; Christine Hauer, Almuthe ; Erwa, Wolfgang ; Jahnel, Jörg</creator><creatorcontrib>Skrabl-Baumgartner, Andrea ; Christine Hauer, Almuthe ; Erwa, Wolfgang ; Jahnel, Jörg</creatorcontrib><description>ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD in children with JIA.Patients and interventions95 patients with JIA were screened for CD using CD-specific antibodies. In case of positivity, a small intestinal biopsy was performed to confirm diagnosis. In addition, HLA genotyping was performed. 110 age-matched and sex-matched Caucasian children from the same geographical area served as controls.ResultsCD was diagnosed in 4 of 95 patients with JIA (4.2%), a rate significantly higher compared with controls (p&lt;0.02) and 14 times higher than in the general population. Twenty-six patients (27.4%) had one of the variants of the risk genotypes. All four patients diagnosed with CD had a HLA-DQ2.5 genotype: one was homozygote, the remainder heterozygote. Twenty-two patients are, judging by their HLA genotypes, at risk of developing CD and require repeated serological screening. None of the 69 patients without HLA-DQ2/DQ8 genotypes had CD-specific antibodies. Screening with HLA genotyping becomes cheaper than screening without after the second determination.ConclusionsIn our cohort of patients with JIA, lack of HLA-DQ2/DQ8 genotypes identified a majority not at risk of CD in whom repeated serological testing is unnecessary. Genotyping is nowadays the most efficient and cost-effective way to screen for CD risk in JIA.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/archdischild-2016-311544</identifier><identifier>PMID: 28232458</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd</publisher><subject>Adolescent ; Age of Onset ; Antibodies ; Antigens ; Arthritis ; Arthritis, Juvenile - economics ; Arthritis, Juvenile - genetics ; Arthritis, Juvenile - immunology ; Autoantibodies - metabolism ; Biopsy ; Celiac disease ; Celiac Disease - diagnosis ; Celiac Disease - economics ; Celiac Disease - genetics ; Celiac Disease - immunology ; Child ; Child, Preschool ; Children ; Children &amp; youth ; Complications and side effects ; Cost-Benefit Analysis ; Early Diagnosis ; Environmental Influences ; Female ; Gastroenterology ; Genotype ; Genotype &amp; phenotype ; Genotypes ; Genotyping ; Genotyping Techniques - economics ; Genotyping Techniques - methods ; Guidelines ; Health aspects ; Histocompatibility antigen HLA ; HLA-DQ Antigens - genetics ; Humans ; Infant ; Intestine ; Juvenile arthritis ; Male ; Medical screening ; Nutrition ; Patients ; Prospective Studies ; Rheumatoid arthritis ; Risk factors ; Screening Tests ; Statistical Analysis</subject><ispartof>Archives of disease in childhood, 2017-07, Vol.102 (7), p.607-611</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.</rights><rights>Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3</citedby><cites>FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1912450940/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1912450940?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21376,21392,27922,27923,33609,33610,33875,33876,43731,43878,73991,74167</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28232458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Skrabl-Baumgartner, Andrea</creatorcontrib><creatorcontrib>Christine Hauer, Almuthe</creatorcontrib><creatorcontrib>Erwa, Wolfgang</creatorcontrib><creatorcontrib>Jahnel, Jörg</creatorcontrib><title>HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis</title><title>Archives of disease in childhood</title><addtitle>Arch Dis Child</addtitle><description>ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD in children with JIA.Patients and interventions95 patients with JIA were screened for CD using CD-specific antibodies. In case of positivity, a small intestinal biopsy was performed to confirm diagnosis. In addition, HLA genotyping was performed. 110 age-matched and sex-matched Caucasian children from the same geographical area served as controls.ResultsCD was diagnosed in 4 of 95 patients with JIA (4.2%), a rate significantly higher compared with controls (p&lt;0.02) and 14 times higher than in the general population. Twenty-six patients (27.4%) had one of the variants of the risk genotypes. All four patients diagnosed with CD had a HLA-DQ2.5 genotype: one was homozygote, the remainder heterozygote. Twenty-two patients are, judging by their HLA genotypes, at risk of developing CD and require repeated serological screening. None of the 69 patients without HLA-DQ2/DQ8 genotypes had CD-specific antibodies. Screening with HLA genotyping becomes cheaper than screening without after the second determination.ConclusionsIn our cohort of patients with JIA, lack of HLA-DQ2/DQ8 genotypes identified a majority not at risk of CD in whom repeated serological testing is unnecessary. Genotyping is nowadays the most efficient and cost-effective way to screen for CD risk in JIA.</description><subject>Adolescent</subject><subject>Age of Onset</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Arthritis</subject><subject>Arthritis, Juvenile - economics</subject><subject>Arthritis, Juvenile - genetics</subject><subject>Arthritis, Juvenile - immunology</subject><subject>Autoantibodies - metabolism</subject><subject>Biopsy</subject><subject>Celiac disease</subject><subject>Celiac Disease - diagnosis</subject><subject>Celiac Disease - economics</subject><subject>Celiac Disease - genetics</subject><subject>Celiac Disease - immunology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Children &amp; youth</subject><subject>Complications and side effects</subject><subject>Cost-Benefit Analysis</subject><subject>Early Diagnosis</subject><subject>Environmental Influences</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Genotype</subject><subject>Genotype &amp; phenotype</subject><subject>Genotypes</subject><subject>Genotyping</subject><subject>Genotyping Techniques - economics</subject><subject>Genotyping Techniques - methods</subject><subject>Guidelines</subject><subject>Health aspects</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA-DQ Antigens - genetics</subject><subject>Humans</subject><subject>Infant</subject><subject>Intestine</subject><subject>Juvenile arthritis</subject><subject>Male</subject><subject>Medical screening</subject><subject>Nutrition</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Rheumatoid arthritis</subject><subject>Risk factors</subject><subject>Screening Tests</subject><subject>Statistical Analysis</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>CJNVE</sourceid><sourceid>M0P</sourceid><recordid>eNqNkU-P0zAQxSMEYrsLXwFZ4sIlix3_zbGqgEWqtBc4W44zaVy5drEdYL89LlkQ4gInS-Pfm3kzr2kQwbeEUPHWJDuPLtvZ-bHtMBEtJYQz9qTZECZULTH2tNlgjGnbK6WumuucjxiTTin6vLnqVEc7xtWmCXf7LTpAiOXh7MIBmYwml3JpvQuAsk0A4VIvMXo0xYRsBO-MRXU8mAzIBfTTRoKAvrkyo-PytUp8_RldPJsyO4tMKnNyxeUXzbPJ-AwvH9-b5vP7d592d-3-_sPH3XbfDtVVaSWTowAKgnR4AEE5ldJOprcSjOinCSYAxuyoaE-kGGQv-TDakdCRGyH4SG-aN2vfc4pfFshFn-q5wHsTIC5Zk54IKhXh8t-okh2XUkla0dd_oce4pFAXuTSsB8U9w5VqV-pgPGgXbAwFvhcbvYcD6Lrn7l5vORY96TnmlVcrb1PMOcGkz8mdTHrQBOtL3PrPuPUlbr3GXaWvHg0twwnG38Jf-VaArsBwOv5_2x_657p3</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Skrabl-Baumgartner, Andrea</creator><creator>Christine Hauer, Almuthe</creator><creator>Erwa, Wolfgang</creator><creator>Jahnel, Jörg</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88I</scope><scope>8A4</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0P</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20170701</creationdate><title>HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis</title><author>Skrabl-Baumgartner, Andrea ; Christine Hauer, Almuthe ; Erwa, Wolfgang ; Jahnel, Jörg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Age of Onset</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Arthritis</topic><topic>Arthritis, Juvenile - economics</topic><topic>Arthritis, Juvenile - genetics</topic><topic>Arthritis, Juvenile - immunology</topic><topic>Autoantibodies - metabolism</topic><topic>Biopsy</topic><topic>Celiac disease</topic><topic>Celiac Disease - diagnosis</topic><topic>Celiac Disease - economics</topic><topic>Celiac Disease - genetics</topic><topic>Celiac Disease - immunology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Children &amp; youth</topic><topic>Complications and side effects</topic><topic>Cost-Benefit Analysis</topic><topic>Early Diagnosis</topic><topic>Environmental Influences</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Genotype</topic><topic>Genotype &amp; phenotype</topic><topic>Genotypes</topic><topic>Genotyping</topic><topic>Genotyping Techniques - economics</topic><topic>Genotyping Techniques - methods</topic><topic>Guidelines</topic><topic>Health aspects</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA-DQ Antigens - genetics</topic><topic>Humans</topic><topic>Infant</topic><topic>Intestine</topic><topic>Juvenile arthritis</topic><topic>Male</topic><topic>Medical screening</topic><topic>Nutrition</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Rheumatoid arthritis</topic><topic>Risk factors</topic><topic>Screening Tests</topic><topic>Statistical Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Skrabl-Baumgartner, Andrea</creatorcontrib><creatorcontrib>Christine Hauer, Almuthe</creatorcontrib><creatorcontrib>Erwa, Wolfgang</creatorcontrib><creatorcontrib>Jahnel, Jörg</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Education Periodicals</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Education Collection</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Education Database</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Skrabl-Baumgartner, Andrea</au><au>Christine Hauer, Almuthe</au><au>Erwa, Wolfgang</au><au>Jahnel, Jörg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis</atitle><jtitle>Archives of disease in childhood</jtitle><addtitle>Arch Dis Child</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>102</volume><issue>7</issue><spage>607</spage><epage>611</epage><pages>607-611</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><abstract>ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD in children with JIA.Patients and interventions95 patients with JIA were screened for CD using CD-specific antibodies. In case of positivity, a small intestinal biopsy was performed to confirm diagnosis. In addition, HLA genotyping was performed. 110 age-matched and sex-matched Caucasian children from the same geographical area served as controls.ResultsCD was diagnosed in 4 of 95 patients with JIA (4.2%), a rate significantly higher compared with controls (p&lt;0.02) and 14 times higher than in the general population. Twenty-six patients (27.4%) had one of the variants of the risk genotypes. All four patients diagnosed with CD had a HLA-DQ2.5 genotype: one was homozygote, the remainder heterozygote. Twenty-two patients are, judging by their HLA genotypes, at risk of developing CD and require repeated serological screening. None of the 69 patients without HLA-DQ2/DQ8 genotypes had CD-specific antibodies. Screening with HLA genotyping becomes cheaper than screening without after the second determination.ConclusionsIn our cohort of patients with JIA, lack of HLA-DQ2/DQ8 genotypes identified a majority not at risk of CD in whom repeated serological testing is unnecessary. Genotyping is nowadays the most efficient and cost-effective way to screen for CD risk in JIA.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd</pub><pmid>28232458</pmid><doi>10.1136/archdischild-2016-311544</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-9888
ispartof Archives of disease in childhood, 2017-07, Vol.102 (7), p.607-611
issn 0003-9888
1468-2044
language eng
recordid cdi_proquest_miscellaneous_1916378157
source Social Science Premium Collection; Education Collection
subjects Adolescent
Age of Onset
Antibodies
Antigens
Arthritis
Arthritis, Juvenile - economics
Arthritis, Juvenile - genetics
Arthritis, Juvenile - immunology
Autoantibodies - metabolism
Biopsy
Celiac disease
Celiac Disease - diagnosis
Celiac Disease - economics
Celiac Disease - genetics
Celiac Disease - immunology
Child
Child, Preschool
Children
Children & youth
Complications and side effects
Cost-Benefit Analysis
Early Diagnosis
Environmental Influences
Female
Gastroenterology
Genotype
Genotype & phenotype
Genotypes
Genotyping
Genotyping Techniques - economics
Genotyping Techniques - methods
Guidelines
Health aspects
Histocompatibility antigen HLA
HLA-DQ Antigens - genetics
Humans
Infant
Intestine
Juvenile arthritis
Male
Medical screening
Nutrition
Patients
Prospective Studies
Rheumatoid arthritis
Risk factors
Screening Tests
Statistical Analysis
title HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T21%3A14%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HLA%20genotyping%20as%20first-line%20screening%20tool%20for%20coeliac%20disease%20in%20children%20with%20juvenile%20idiopathic%20arthritis&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Skrabl-Baumgartner,%20Andrea&rft.date=2017-07-01&rft.volume=102&rft.issue=7&rft.spage=607&rft.epage=611&rft.pages=607-611&rft.issn=0003-9888&rft.eissn=1468-2044&rft_id=info:doi/10.1136/archdischild-2016-311544&rft_dat=%3Cgale_proqu%3EA506919505%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1912450940&rft_id=info:pmid/28232458&rft_galeid=A506919505&rfr_iscdi=true